← Human Trials & Peer-Reviewed Studies
Changes in blood pressure and lipid levels in young women consuming a vitamin D-fortified skimmed milk: a randomised controlled trial.
Plain-language guide to PMID 24317556 (2013): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc, low blood pressure and orthostatic hypotension.
Key Facts
- PMID
- 24317556
- Journal
- Nutrients
- Year
- 2013
- Study type
- Randomized Controlled Trial
- Authors
- Toxqui L et al. (5 authors)
- DOI
- 10.3390/nu5124966
What This Study Did, in Plain Language
What Was Tested
Researchers studied Vitamin D, K2, Magnesium and Zinc in the context of low blood pressure and orthostatic hypotension in this randomized controlled trial publication.
To know the effects of the consumption of a vitamin D-fortified skimmed milk on glucose, lipid profile, and blood pressure in young women.
Why It Was Studied
Vitamin D exerts a variety of extra-skeletal functions.
Who Took Part
By PubMed's age tags, the people studied were teenagers, young adults and adults, women only.
A reference group (n = 56) of iron-sufficient women was also recruited.
How the Study Was Run
The design is described as randomized, double-blind, placebo-controlled and parallel-group.
The participants were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.
As a double-blind Vitamin D, K2, Magnesium and Zinc study, the assignments were hidden from both participants and investigators until the end.
A placebo (an inactive look-alike) gave the Vitamin D, K2, Magnesium and Zinc group a baseline to be compared against.
The Vitamin D, K2, Magnesium and Zinc group and the comparison group ran side by side rather than switching.
What Was Measured
The subject headings attached to it are Anthropometry, Blood Glucose, Blood Pressure, Cholesterol, HDL, Cholesterol, LDL, Dietary Supplements and Food, Fortified.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in people with low blood pressure and orthostatic hypotension.
The abstract goes on to report its results in about 5 sentences; this page does not restate them, so read the paper for the findings and their limits.
The publication is from 2013 (Nutrients), a journal based in Switzerland.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, Low blood pressure and orthostatic hypotension research.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
- Low blood pressure and orthostatic hypotension research
- Vitamin D, K2, Magnesium and Zinc in the library
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.